Labeler
Accord Healthcare Inc. NDC Codes
Accord Healthcare Inc. lists 227 finished drug products in the FDA NDC Directory under NDC labeler code 16729.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Levothyroxine sodium, Lenalidomide, lurasidone hydrochloride, Hydroxychloroquine Sulfate, Glycopyrrolate, Tadalafil, Vilazodone Hydrochloride, Pemetrexed, Atropine Sulfate, Furosemide, Methylphenidate Hydrochloride, Olmesartan Medoxomil And Hydrochlorothiazide, Diltiazem Hydrochloride, Dofetilide, Cinacalcet
- Active ingredients
- Levothyroxine sodium, Lenalidomide, Lurasidone hydrochloride, Hydroxychloroquine sulfate, Glycopyrrolate, Tadalafil, Vilazodone hydrochloride, Pemetrexed disodium hemipentahydrate, Atropine sulfate, Furosemide, Methylphenidate hydrochloride, Olmesartan medoxomil
- NDC labeler codes
- 16729
- Strengths (from the 100 most recently listed products)
- Glycopyrrolate .2 mg/mL; Furosemide 10 mg/mL; Hydrochlorothiazide 12.5 mg/1; Olmesartan medoxomil 40 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Lenalidomide 2.5 mg/1; Lenalidomide 25 mg/1; Lenalidomide 15 mg/1; Lenalidomide 5 mg/1; Lenalidomide 20 mg/1; Lenalidomide 10 mg/1; Clomiphene citrate 50 mg/1; Alcohol 1 mL/mL; Teriflunomide 7 mg/1; Teriflunomide 14 mg/1; Regadenoson .08 mg/mL; Lurasidone hydrochloride 20 mg/1; Lurasidone hydrochloride 40 mg/1; Lurasidone hydrochloride 60 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Capsule, Injection, Powder, Lyophilized, For solution, Injection, Solution, Tablet, Extended release, Capsule, Extended release, Capsule, Delayed release, Ointment, Cream
- Routes
- Oral, Intravenous, Intramuscular, Topical, Subcutaneous, Sublingual, Percutaneous, Endotracheal, Intramedullary
- Drug classes (FDA established)
- l-Thyroxine, Atypical Antipsychotic, Anticholinergic, Cholinergic Muscarinic Antagonist, Thalidomide Analog, Folate Analog Metabolic Inhibitor, Antimalarial, Antirheumatic Agent, Phosphodiesterase 5 Inhibitor, Alkylating Drug, Loop Diuretic, Central Nervous System Stimulant, Angiotensin 2 Receptor Blocker, Thiazide Diuretic, Calcium Channel Blocker, Antiarrhythmic, Calcium-sensing Receptor Agonist, Pyrimidine Synthesis Inhibitor, Pyridone, Nucleoside Metabolic Inhibitor, Anti-coagulant, Direct Thrombin Inhibitor, Opioid Antagonist, Partial Opioid Agonist, Lipopeptide Antibacterial, Calcineurin Inhibitor Immunosuppressant, Aminoketone, P2Y12 Platelet Inhibitor, Estrogen Agonist/Antagonist, Pharmacologic Cardiac Stress Test Agent, Sphingosine 1-phosphate Receptor Modulator, Carbonic Anhydrase Inhibitor, Estrogen Receptor Antagonist, Topoisomerase Inhibitor, Dietary Cholesterol Absorption Inhibitor, Serotonin Reuptake Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 137 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Aripiprazole | Aripiprazole 30 mg/1 | TabletOral | 16729-283 | 16729-0283-0116729-0283-10 | — |
| Sertraline Hydrochloride | Sertraline hydrochloride 25 mg/1 | Tablet, Film coatedOral | 16729-215 | 16729-0215-1016729-0215-1516729-0215-16 | — |
| Sertraline Hydrochloride | Sertraline hydrochloride 50 mg/1 | Tablet, Film coatedOral | 16729-216 | 16729-0216-1516729-0216-16 | — |
| Sertraline Hydrochloride | Sertraline hydrochloride 100 mg/1 | Tablet, Film coatedOral | 16729-217 | 16729-0217-1516729-0217-16 | — |
| Dexmedetomidine | Dexmedetomidine hydrochloride 100 ug/mL | Injection, SolutionIntravenous | 16729-239 | 16729-0239-93 | — |
| oxybutynin chloride | Oxybutynin chloride 10 mg/1 | Tablet, Extended releaseOral | 16729-318 | 16729-0318-0116729-0318-16 | — |
| Buspirone Hydrochloride | Buspirone hydrochloride 5 mg/1 | TabletOral | 16729-200 | 16729-0200-0116729-0200-16 | — |
| Buspirone Hydrochloride | Buspirone hydrochloride 10 mg/1 | TabletOral | 16729-202 | 16729-0202-0116729-0202-16 | — |
| Buspirone Hydrochloride | Buspirone hydrochloride 15 mg/1 | TabletOral | 16729-203 | 16729-0203-0116729-0203-12 | — |
| Buspirone Hydrochloride | Buspirone hydrochloride 30 mg/1 | TabletOral | 16729-289 | 16729-0289-12 | — |
| oxybutynin chloride | Oxybutynin chloride 5 mg/1 | Tablet, Extended releaseOral | 16729-317 | 16729-0317-0116729-0317-16 | — |
| oxybutynin chloride | Oxybutynin chloride 15 mg/1 | Tablet, Extended releaseOral | 16729-319 | 16729-0319-01 | — |
| Cisplatin | Cisplatin 1 mg/mL | InjectionIntravenous | 16729-288 | 16729-0288-1116729-0288-38 | — |
| Buspirone Hydrochloride | Buspirone hydrochloride 7.5 mg/1 | TabletOral | 16729-201 | 16729-0201-01 | — |
| Quetiapine Fumarate | Quetiapine fumarate 400 mg/1 | Tablet, Extended releaseOral | 16729-097 | 16729-0097-12 | — |
| Rosuvastatin | Rosuvastatin calcium 5 mg/1 | Tablet, Film coatedOral | 16729-284 | 16729-0284-1516729-0284-17 | — |
| Rosuvastatin | Rosuvastatin calcium 10 mg/1 | Tablet, Film coatedOral | 16729-285 | 16729-0285-1516729-0285-17 | — |
| Rosuvastatin | Rosuvastatin calcium 20 mg/1 | Tablet, Film coatedOral | 16729-286 | 16729-0286-1516729-0286-17 | — |
| Rosuvastatin | Rosuvastatin calcium 40 mg/1 | Tablet, Film coatedOral | 16729-287 | 16729-0287-1016729-0287-1516729-0287-17 | — |
| ondansetron | Ondansetron 2 mg/mL | InjectionIntramuscular, Intravenous | 16729-298 | 16729-0298-05 | J2405 |
| Paricalcitol | Paricalcitol 2 ug/mL | Injection, SolutionIntravenous | 16729-310 | 16729-0310-0816729-0310-63 | — |
| Paricalcitol | Paricalcitol 5 ug/mL | Injection, SolutionIntravenous | 16729-311 | 16729-0311-0816729-0311-3016729-0311-63+1 more | — |
| Capecitabine | Capecitabine 150 mg/1 | Tablet, Film coatedOral | 16729-072 | 16729-0072-12 | — |
| Capecitabine | Capecitabine 500 mg/1 | Tablet, Film coatedOral | 16729-073 | 16729-0073-29 | — |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | 16729-134 | 16729-0134-0116729-0134-16 | — |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | 16729-135 | 16729-0135-0116729-0135-16 | — |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | 16729-213 | 16729-0213-0116729-0213-17 | — |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | 16729-211 | 16729-0211-0116729-0211-17 | — |
| Etoposide | Etoposide 20 mg/mL | InjectionIntravenous | 16729-114 | 16729-0114-0816729-0114-1116729-0114-31 | — |
| Amitriptyline Hydrochloride | Amitriptyline hydrochloride 150 mg/1 | Tablet, Film coatedOral | 16729-176 | 16729-0176-01 | — |
| Amitriptyline Hydrochloride | Amitriptyline hydrochloride 10 mg/1 | Tablet, Film coatedOral | 16729-171 | 16729-0171-0116729-0171-17 | — |
| Amitriptyline Hydrochloride | Amitriptyline hydrochloride 100 mg/1 | Tablet, Film coatedOral | 16729-175 | — | — |
| simvastatin | Simvastatin 5 mg/1 | Tablet, Film coatedOral | 16729-156 | 16729-0156-1016729-0156-1516729-0156-17 | — |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | 16729-276 | 16729-0276-1116729-0276-38 | — |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | 16729-276 | 16729-0276-6716729-0276-68 | — |
| Methotrexate | Methotrexate 25 mg/mL | InjectionIntra-arterial, Intramuscular, Intrathecal, Intravenous | 16729-277 | 16729-0277-0316729-0277-3016729-0277-35 | — |
| Finasteride | Finasteride 1 mg/1 | Tablet, Film coatedOral | 16729-089 | 16729-0089-1016729-0089-15 | — |
| topotecan hydrochloride | Topotecan hydrochloride 4 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 16729-151 | 16729-0151-31 | — |
| Carbidopa And Levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | Tablet, Extended releaseOral | 16729-078 | 16729-0078-0116729-0078-17 | — |
| Carbidopa And Levodopa | Carbidopa 50 mg/1; Levodopa 200 mg/1 | Tablet, Extended releaseOral | 16729-079 | 16729-0079-0116729-0079-17 | — |
| Docetaxel | Docetaxel anhydrous 20 mg/mL | Injection, Solution, ConcentrateIntravenous | 16729-267 | 16729-0267-6316729-0267-6416729-0267-65 | — |
| Hydrochlorothiazide | Hydrochlorothiazide 12.5 mg/1 | TabletOral | 16729-182 | 16729-0182-0116729-0182-17 | — |
| Montelukast Sodium | Montelukast sodium 10 mg/1 | Tablet, Film coatedOral | 16729-119 | 16729-0119-1016729-0119-1516729-0119-17 | — |
| Hydrochlorothiazide | Hydrochlorothiazide 25 mg/1 | TabletOral | 16729-183 | 16729-0183-0116729-0183-17 | — |
| Hydrochlorothiazide | Hydrochlorothiazide 50 mg/1 | TabletOral | 16729-184 | 16729-0184-0116729-0184-17 | — |
| Escitalopram | Escitalopram oxalate 20 mg/1 | Tablet, Film coatedOral | 16729-170 | 16729-0170-0116729-0170-17 | — |
| Escitalopram | Escitalopram oxalate 10 mg/1 | Tablet, Film coatedOral | 16729-169 | 16729-0169-0116729-0169-17 | — |
| Escitalopram | Escitalopram oxalate 5 mg/1 | Tablet, Film coatedOral | 16729-168 | 16729-0168-0116729-0168-17 | — |
| Quetiapine | Quetiapine fumarate 50 mg/1 | Tablet, Film coatedOral | 16729-146 | 16729-0146-0116729-0146-17 | — |
| Quetiapine | Quetiapine fumarate 100 mg/1 | Tablet, Film coatedOral | 16729-147 | 16729-0147-0116729-0147-17 | — |
Accord Healthcare Inc.: common questions
- What is Accord Healthcare Inc.'s NDC labeler code?
- 16729. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Accord Healthcare Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.